Innovation in
Neuroscience
Understanding and improving neurological & neuropsychiatric disorders
The Burden of Illness
One billion of us around the world are silently struggling—living with mental health conditions that shape our every thought, feeling, every day.
Each year, eight million lives end too soon, with 10 years of life stolen. The cost isn't just measured in the $5 trillion global economic burden—it's measured in dreams deferred, relationships fractured and potential never realized.
1 Billion
People affected by mental health conditions worldwide
8 Million
Lives lost annually with 10 years of life stolen
$5 Trillion
Global economic burden of mental health disorders
Our Mission
At Synendos, we're working on new therapies for neuropsychiatric and neurological disorders that target the root cause, not just the symptoms.
Synendos is a clinical-stage neuroscience company targeting the Endocannabinoid System to restore the brain's natural functioning. Our immediate focus is on anxiety and mood-related diseases—particularly conditions like general anxiety disorder (GAD) and post-traumatic stress disorder (PTSD)—where endocannabinoid deficiency leads to suffering, and treatment options fall short.
Our goal quite simply is to give patients their lives back – at home, at work, and in society.
Clinical-Stage Research
Targeting the Endocannabinoid System to restore the brain's natural functioning through innovative therapeutic approaches.
Focus on Anxiety & Mood Disorders
Specialized treatment for GAD and PTSD, addressing endocannabinoid deficiency where traditional options fall short.
Updates and Insights
Stay informed about our latest developments and research
Andrea Chicca CEO and Simon Russell CCO will be present in London next week during the Jefferies Global Healthcare Conference week from 17-20th November.
New findings in endocannabinoid system research show promising results for anxiety disorder treatment protocols.
Phase II clinical trials continue to demonstrate significant improvements in patient outcomes for PTSD treatment.
Need More Details?
We are here to assist. Contact us by email or via our social media channels.
Email Us
info@synendos.com
Visit Us
Clinical Research Center
Innovation District
Follow Us
